argus

Biocon Ltd.

NSE: BIOCONINE376G0101365,391 Cr

Timeline

Time (IST)TypeMEventSrc
27 Mar, 11:58 amBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026 - Appointment of CFO and Resignation of Interim FOnse
27 Mar, 11:58 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
27 Mar, 11:54 amBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026 - Appointment of CEO and MD, and resignation of CEO and MD.nse
12 Mar, 09:20 pmBiocon Limited has informed the Exchange regarding 'Notification to Stock Exchanges'.nse
03 Mar, 11:09 pmBiocon Limited has informed the Exchange about Acquisitionnse
03 Mar, 11:04 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
25 Feb, 06:42 amBiocon Limited has informed the Exchange about Investor Presentationnse
25 Feb, 06:37 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
24 Feb, 09:05 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
24 Feb, 09:04 pmBiocon Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Biocon obtains approval for weight management drug,Liraglutide, in the United States".nse
17 Feb, 05:20 pmBiocon Limited has informed the Exchange about Transcriptnse
17 Feb, 05:16 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
13 Feb, 03:44 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
13 Feb, 03:36 pmBiocon Limited has informed the Exchange about Link of Recordingnse
13 Feb, 08:26 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
13 Feb, 08:23 amBiocon Limited has informed the Exchange about Investor Presentationnse
12 Feb, 07:47 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
12 Feb, 07:47 pmMonitoring Agency Report for the quarter ended on December 31, 2025nse
12 Feb, 07:42 pmBiocon Limited has informed the Exchange regarding a press release dated February 12, 2026, titled "Biocon Q3FY26 Operating Revenue at Rs 4,173 Cr Q3FY26 EBITDA at Rs 951 Cr Q3FY26 Net Profit at Rs 144 Cr ".nse
12 Feb, 07:41 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Feb, 07:28 pmBiocon Ltd - 532523 - Outcome Of Board Meeting - In-Principle Approval Of Acquisitionbse
12 Feb, 07:28 pmOutcome of Board Meeting - In-principle approval of Acquisitionnse
12 Feb, 07:15 pmBiocon Ltd - 532523 - Board Meeting Outcome for Outcome Of Board Meeting- Quarterly Resultsbse
12 Feb, 07:13 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2026.nse
12 Feb, 07:11 pmBiocon Ltd - 532523 - Outcome Of Board Meeting-Financial Resultsbse
12 Feb, 07:10 pmBiocon Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
07 Feb, 04:12 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 Feb, 01:03 pmBiocon Limited has informed the Exchange regarding a press release dated February 07, 2026, titled "Fitch Ratings Upgrades Biocon Biologics Outlook from Stable to Positive ".nse
30 Jan, 08:23 pmBiocon Ltd - 532523 - Buyback Of Commercial Papersbse
28 Jan, 07:05 pmBiocon Limited has informed the Exchange about Intimation of Record Date for Buy Back of Listed Commercial Paper Issued by the Companynse
28 Jan, 06:52 pmBiocon Limited has informed the Exchange about Intimation of record date for buy back of listed Commercial Paper issued by the Companynse
28 Jan, 06:20 pmBiocon Limited has informed the Exchange regarding 'Notification to Stock Exchanges'.nse
28 Jan, 08:46 amBiocon Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "S&P Global Upgrades Biocon Biologics Credit Rating To BB+ Revises Outlook to Stable ".nse
28 Jan, 08:41 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
21 Jan, 08:12 pmBiocon Limited has informed the Exchange regarding 'Certificate pursuant to SEBI Master Circular no. SEBI/HO/DDHS/DDHSPoD/P/CIR/2025/0000000137 dated October 15, 2025'.nse
21 Jan, 07:59 pmBiocon Limited has informed the Exchange about Update on Acquisitionnse
21 Jan, 07:58 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
20 Jan, 10:07 amBiocon Ltd - 532523 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
15 Jan, 09:16 amBiocon Limited has informed the Exchange regarding a press release dated January 14, 2026, titled "Biocon Limited Concludes Rs 4,150 Crore (app USD 460 million) Equity Fundraise through a Qualified Institutions Placement (QIP)".nse
15 Jan, 12:00 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
14 Jan, 11:54 pmBiocon Limited has informed the Exchange regarding allotment of 11,26,64,585 securities pursuant to Qualified Institution Placement at its meeting held on January 14, 2026nse
14 Jan, 11:51 pmBiocon Limited has informed the Exchange about allotment under Qualified Institutions Placementnse
14 Jan, 11:49 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Allotmentbse
14 Jan, 11:48 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placementbse
14 Jan, 10:31 pmBiocon Limited has informed the Exchange about Qualified Institutions Placement - Approval and adoption of Placement Documentnse
14 Jan, 10:30 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placementbse
14 Jan, 10:16 pmBiocon Limited has informed the Exchange about Qualified Institutions Placement - Issue Closurense
14 Jan, 10:13 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placementbse
13 Jan, 04:54 pmBiocon Ltd - 532523 - Board Meeting Intimation for Intimation For The Board Meeting And Earnings Conference Call For Analysts And Investorsbse
12 Jan, 04:50 pmBiocon Limited has informed the Exchange about Qualified Institutions Placement - Issue Openingnse